Tell Us What You Think

Rate your Quintiles.com experience

Subscribe to Email Based on Your Interests

Set preferences

Information Library

Case Studies - Phase II/III

To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.

See all

  • Sort by: Most Recent
  • Title
  • Hepatitis B Vaccine-Successful Study Strategy in Asia

    November 9, 2009
    Quintiles helped a customer overcome recruitment and regulatory challenges for a Hepatitis B vaccine study in Asia.

  • Coordinating Safety Across Functions and Phases

    November 3, 2009
    A customer faced significant challenges with clinical and post-marketing safety. Without previous drug safety experience, they needed an ally who could provide a full range of safety and risk management solutions.

  • Enabling Transformation

    September 30, 2009
    Biovitrum found an ideal opportunity to transform itself into a fully integrated specialty pharmaceutical company from a biotech discovery and early clinical development company.

  • Nasal Influenza Vaccine

    September 22, 2009
    Quintiles helped a customer overcome recruitment and regulatory challenges for a nasal influenza vaccine study in Argentina, Brazil and South Africa.

  • Testing Disaster Readiness for Our Customer's Protection

    August 10, 2009
    Learn how Quintiles' planning protects trial data and provides seamless business continuity for clinical trials.

  • eCTD Submissions

    June 21, 2009
    Read this case study which details information on eCTD submissions.

  • Advanced Gastric Cancer

    May 12, 2009
    To meet the challenges in patient recruitment, Quintiles relied on its therapeutic experience and extensive global site network to select the study sites most likely to treat patients meeting study entry criteria. In order to assist oncologists in working with the primary-tumor-related inclusion criteria, CRAs provided training to all sites based on a radiological briefing document.